Skip to main content
News_Latz_03.2023
Human skin cells with "healthy" mitochondria (light blue): - NLRP10 (yellow-green) is distributed over the entire contents of the cell, apart from the nucleus (blue-violet).
© Image: Kim S. Robinson / Skin Research Institute Singapore

News categories: Publication

Loss of mitochondrial integrity induces inflammasome activation

Function of NOD-like receptor NLRP10 revealed

The recognition of pathogens and sterile damage may result in pyroptotic cell death and inflammation. This is brought about by the formation of protein complexes called inflammasomes. ImmunoSensation2 speaker Prof. Eicke Latz and his team at the University of Bonn, together with colleagues from the University of Singapore, now revealed a new function for the inflammasome component NLRP10. The sensor warns of damage to the mitochondria. If it does not function properly, chronic skin diseases can result. The sensor may also be important for unimpaired heart and bowel function. The results have now been published in the journal Nature Immunology.


Every cell in the body has numerous sensors that monitor its function. Some sound the alarm after a virus attack, for instance; others kick in when any kind of damage threatens the cell's survival. "We have now discovered that a molecule called NLRP10 also acts as a sensor," explains Prof. Dr. Eicke Latz, head of the Institute of Innate Immunity at the University Hospital Bonn. "This was completely unknown until now."

The scientists were able to show that NLRP10 detects when the mitochondria in the cell malfunction and lose their integrity. As soon as an NLRP10 sensor detects damage to mitochondria, inflammasome formation is initialized, ultimately causing the cell to perish and be disposed of by summoned immune cells.

Fire alarm prevents long-lasting smoldering fire

"This process is hugely important," explains Latz, who is also a member of the Transdisciplinary Research Area "Life and Health" at the University of Bonn. "Disruption of this mechanism can result in chronic inflammation," the researcher emphasizes. "Killing cells with mitochondrial defects may sound drastic. Ultimately, however, this step prevents more serious consequences."

Not all cells in the body express NLRP10. The sensor occurs primarily in the outermost skin layer, the stratum granulosum. The skin is directly exposed to environmental stimuli such as UV radiation, but also pathogens. This could potentially result in accumulated damage. The mechanism described now ensures that affected cells are effectively disposed of. "If a mutation causes the NLRP10 sensor to malfunction, this can result in a chronic skin inflammation called atopic dermatitis," explains Dr. Tomasz Próchnicki, who performed an important part of the experiments for his doctorate in Latz's research group.

Sensor is also found in the intestinal wall and heart

Large quantities of NLRP10 are also found in the intestinal wall cells. These also have regular contact with pathogens and potentially harmful substances. Another organ in which the sensor can be detected is the heart: It is particularly dependent on a well-functioning energy supply. This may make it especially important to quickly kill and replace cells with defective mitochondria.

The study may potentially also open up new therapeutic perspectives. "It is conceivable to specifically modulate the NLRP10 sensor using certain substances in order to stimulate the formation of inflammasomes," Latz explains. "This approach might enable chronic skin diseases to be better controlled."


Funding

In addition to the University Hospital and the University of Bonn, the Skin Research Institute of Singapore, the Technical University of Dresden and the University of Hohenheim were involved in the work. The
study was funded by the German Research Foundation (DFG), by EU funds under the European Union's Horizon 2020 program, by the Helmholtz Association, and by the Nation Research Foundation in Singapore.

Publication

Tomasz Próchnicki et al.: Mitochondrial damage activates the NLRP10 inflammasome; Nature Immunology; DOI: 10.1038/s41590-023-01451-y


Contact

Prof. Dr. Eicke Latz

Institute of Innate Immunity of the University of Bonn

Co-speaker of the Cluster of Excellence "ImmunoSensation2"

Tel. +49 228 287-51239

E-mail: eicke.latz@uni-bonn.de


Related news

Scientists that contributed to the study

News categories: Publication

New way to prevent duodenal cancer

People with the hereditary disease familial adenomatous polyposis (FAP) have a greatly increased risk of developing a malignant tumor of the duodenum. Researchers at the University Hospital Bonn (UKB) and the Cluster of Excellence ImmunoSensation2 at the University of Bonn have now discovered a mechanism in the local immune system that can drive the development of cancer. They see this as a promising new approach to preventing duodenal carcinoma in people with FAP. The results have now been published in the journal "Nature Communications".
View entry
Kathrin Leppek Publication PM

News categories: Publication

Starting points for the control of protein synthesis

The research field of "cellular IRESes" lay dormant for decades, as there was no uniform standard of reliable methods for the clear characterization of these starting points for the ribosome-mediated control of gene expression. Researchers at the University Hospital Bonn (UKB) and the University of Bonn, in collaboration with Stanford University in California (USA), have now developed a toolbox as a new gold standard for this field. The results of their work have been published in The EMBO Journal.
View entry
Pandyra Publication Graphical Abstract

News categories: Publication

Genetic mutation affects survival after viral infection

Scientists discovered that haploinsufficiency in the Pax5 gene affects antiviral responses. The study was led by Prof. Dr. Aleksandra Pandyra from the Institute of Clinical Chemistry and Clinical Pharmacology at the University Hospital Bonn in collaboration with Prof. Dr. Arndt Borkhardt, Clinic Director at the Pediatric Oncology at the University Hospital Düsseldorf. The findings were published in the latest edition of EMBO Molecular Medicine.
View entry

Back to the news overview